The expression of TMEM176B is up-regulated in the tumor blood vessels of human renal cell carcinoma specimens, suggesting that it is implicated in tumor angiogenesis and could be a target of anti-angiogenesis therapy for cancer patients (Otsubo et al., 2014). The gene discussed is TMEM176B; the disease is cancer.